Acadia Pharmaceuticals Inc. (ACAD) free cash flow

Free cash flow · fiscal 2025
$105.15M

Acadia Pharmaceuticals Inc. (ACAD) generated free cash flow of $105.15M in fiscal 2025 (the year ended December 31, 2025). That is 33.1% lower than the $157.20M of fiscal 2024. Figures as of 18 Nov 2026, 11:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$105.15M
Change on fiscal 2024
−33.1%
Highest on record
$157.20Mfiscal 2024
Lowest on record
-$218.57Mfiscal 2017
Fiscal years on record
142011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Acadia Pharmaceuticals Inc. free cash flow, in more detail

Across the 14 fiscal years on record (2011–2025), the highest was $157.20M in fiscal 2024 and the lowest -$218.57M in fiscal 2017.

History · 14 fiscal years

Free cash flow by fiscal year

Acadia Pharmaceuticals Inc. free cash flow, year by year

Acadia Pharmaceuticals Inc. (ACAD) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$105.15M 33.1% down
2024$157.20M 844.0% up
2023$16.65M—
2022-$114.04M—
2021-$126.78M—
2020-$143.75M—
2019-$152.26M—
2018-$169.57M—
2017-$218.57M—
2016-$209.91M—
2015-$123.94M—
2014-$66.61M—
2013-$32.39M—
2011-$19.90M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on ACAD

Acadia Pharmaceuticals Inc., figure by figure

Acadia Pharmaceuticals Inc. (ACAD) overview: price, valuation and scorecard

Acadia Pharmaceuticals Inc. free cash flow: questions and answers

What is Acadia Pharmaceuticals Inc.'s free cash flow?

Acadia Pharmaceuticals Inc. (ACAD) generated free cash flow of $105.15M in fiscal 2025 (the year ended December 31, 2025). That is 33.1% lower than the $157.20M of fiscal 2024.

What are the highest and lowest free cash flow figures on record for Acadia Pharmaceuticals Inc.?

Across the 14 fiscal years on record (2011–2025), the highest was $157.20M in fiscal 2024 and the lowest -$218.57M in fiscal 2017.

How is Acadia Pharmaceuticals Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Acadia Pharmaceuticals Inc. it is on record here for 14 fiscal years, 2011 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Acadia Pharmaceuticals Inc. (ACAD) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/ACAD/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.